INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 January 2014
|
Total net assets |
£197.5m |
|
NAV per share |
358.0p |
|
Share price |
306.0p |
|
Total value of unquoted investments |
£25.6m |
|
Total number of portfolio companies |
102 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Gilead |
7.6 |
|
Biogen |
6.8 |
|
Regeneron |
5.5 |
|
Celgene |
5.2 |
|
Amgen |
4.8 |
|
Alexion |
4.1 |
|
Illumina |
4.0 |
|
Vertex |
3.5 |
|
Fluidigm |
2.8 |
|
Mylan |
2.7 |
|
|
----------- |
|
Total |
47.0 |
|
Trust Characteristics |
% NAV |
|
Profitable |
54 |
|
Turning Profitable 2015 |
11 |
|
Unprofitable |
35 |
|
|
----------- |
|
Total |
100 |
|
Geographical Allocation |
% NAV |
|
United States & Canada |
90 |
|
Europe & UK |
10 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% NAV |
|
Quoted |
88 |
|
Unquoted |
12 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
24 FEBRUARY 2014